Internal Medicine Specialist warns of rare diabetes complication linked to SGLT2 inhibitors
Nigerian internal medicine specialist Dr. Jerry Adeyemo, based in Germany, has warned about a rare but serious complication associated with SGLT2 inhibitors, a widely used class of drugs for managing Type 2 diabetes. Dr. Adeyemo’s study focuses on a 63-year-old male patient with Type 2 diabetes and cardiovascular disease who...
Read more